Incorporation of lysosomal sequestration in the mechanistic model for prediction of tissue distribution of basic drugs

Antonini, 1991, Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture, Biochem. Pharmacol., 42, S151, 10.1016/0006-2952(91)90405-T

Appelqvist, 2013, The lysosome: from waste bag to potential therapeutic target, J. Mol. Cell Biol., 5, 214, 10.1093/jmcb/mjt022

Berezhkovskiy, 2004, Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination, J. Pharm. Sci., 93, 1628, 10.1002/jps.20073

Blouin, 1977, Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study, J. Cell Biol., 72, 441, 10.1083/jcb.72.2.441

Chintagari, 2010, Vacuolar ATPase regulates surfactant secretion in rat alveolar type II cells by modulating lamellar body calcium, PLoS One, 5, 10.1371/journal.pone.0009228

Choi, 2013, In silico modeling to predict drug-induced phospholipidosis, Toxicol. Appl. Pharmacol., 269, 195, 10.1016/j.taap.2013.03.010

Condron, 1994, Morphometric analysis of renal proximal tubules in cadmium-treated rats, J. Submicrosc. Cytol. Pathol., 26, 51

Corrin, 1968, Lysosomal aryl sulphatase in pulmonary alveolar cells, For. Hist., 15, 95

Corrin, 1969, Ultrastructural localization of acid phosphatase in the rat lung, J. Anat., 104, 65

Crapo, 1983, Morphometric characteristics of cells in the alveolar region of mammalian lungs, Am. Rev. Respir. Dis., 128, S42

Daniel, 1997, Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs, Pharmacol. Toxicol., 80, 62, 10.1111/j.1600-0773.1997.tb00285.x

Daniel, 1995, The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues, Pharmacol. Toxicol., 77, 402, 10.1111/j.1600-0773.1995.tb01050.x

Daum, 1985, Lipids of mitochondria, Biochim. Biophys. Acta, 822, 1, 10.1016/0304-4157(85)90002-4

van der Deen, 2007, Cigarette smoke extract affects functional activity of MRP1 in bronchial epithelial cells, J. Biochem. Mol. Toxicol., 21, 243, 10.1002/jbt.20187

Duvvuri, 2004, Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60, J. Biol. Chem., 279, 32367, 10.1074/jbc.M400735200

Galetin, 2014, Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling, Methods Mol. Biol., 1113, 255, 10.1007/978-1-62703-758-7_13

Geisow, 1981, Temporal changes of lysosome and phagosome pH during phagolysosome formation in macrophages: studies by fluorescence spectroscopy, J. Cell Biol., 89, 645, 10.1083/jcb.89.3.645

Gekle, 1995, Endosomal alkalinization reduces Jmax and Km of albumin receptor-mediated endocytosis in OK cells, Am. J. Phys., 268, F899

Golabek, 2000, CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells, Mol. Genet. Metab., 70, 203, 10.1006/mgme.2000.3006

Graham, 2012, Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in rat, J. Pharm. Pharmacol., 64, 383, 10.1111/j.2042-7158.2011.01429.x

Grube, 2011, Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy, Am. J. Pathol., 178, 2547, 10.1016/j.ajpath.2011.02.020

Haggie, 2009, Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis, J. Biol. Chem., 284, 7681, 10.1074/jbc.M809161200

Hallifax, 2007, Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction, Drug Metab. Dispos., 35, 1325, 10.1124/dmd.107.015131

Hodge, 2007, Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease, Am. J. Respir. Cell Mol. Biol., 37, 748, 10.1165/rcmb.2007-0025OC

Jansson, 2008, Prediction of drug tissue to plasma concentration ratios using a measured volume of distribution in combination with lipophilicity, J. Pharm. Sci., 97, 2324, 10.1002/jps.21130

Jones, 2015, Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective, Clin. Pharmacol. Ther., 97, 247, 10.1002/cpt.37

Kazmi, 2013, Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells), Drug Metab. Dispos., 41, 897, 10.1124/dmd.112.050054

Kharbanda, 1997, Flow cytometric analysis of vesicular pH in rat hepatocytes after ethanol administration, Hepatology, 26, 929, 10.1002/hep.510260419

Ling, 1996, Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells, J. Am. Soc. Nephrol., 7, 73, 10.1681/ASN.V7173

Logan, 2012, Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications, Expert Opin. Drug Metab. Toxicol., 8, 943, 10.1517/17425255.2012.691165

MacIntyre, 1988, The potential role of lysosomes in tissue distribution of weak bases, Biopharm. Drug Dispos., 9, 513, 10.1002/bod.2510090602

MacIntyre, 1988, Role of lysosomes in hepatic accumulation of chloroquine, J. Pharm. Sci., 77, 196, 10.1002/jps.2600770303

Mellman, 1986, Acidification of the endocytic and exocytic pathways, Annu. Rev. Biochem., 55, 663, 10.1146/annurev.bi.55.070186.003311

Miklavc, 2014, Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis, PLoS One, 9, 10.1371/journal.pone.0084926

Myers, 1991, Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload, J. Clin. Invest., 88, 1207, 10.1172/JCI115423

Myers, 1995, Dynamic measurements of the acute and chronic effects of lysosomotropic agents on hepatocyte lysosomal pH using flow cytometry, Hepatology, 22, 1519

Ohkuma, 1978, Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents, Proc. Natl. Acad. Sci. U. S. A., 75, 3327, 10.1073/pnas.75.7.3327

Ouar, 2003, Inhibitors of vacuolar H+−ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells, Biochem. J., 370, 185, 10.1042/bj20021411

Pfaller, 1982, Structure function correlation on rat kidney. Quantitative correlation of structure and function in the normal and injured rat kidney, Adv. Anat. Embryol. Cell Biol., 70, 1, 10.1007/978-3-642-68287-2_1

Poulin, 2000, A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery, J. Pharm. Sci., 89, 16, 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E

Reasor, 2006, Drug-induced phospholipidosis: issues and future directions, Expert Opin. Drug Saf., 5, 567, 10.1517/14740338.5.4.567

Regec, 1989, Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility, Biochem. Pharmacol., 38, 2527, 10.1016/0006-2952(89)90098-1

Rodgers, 2006, Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions, J. Pharm. Sci., 95, 1238, 10.1002/jps.20502

Rodgers, 2005, Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases, J. Pharm. Sci., 94, 1259, 10.1002/jps.20322

Rostami-Hodjegan, 2012, Physiologically based pharmacokinetic (PBPK) modeling: it is here to stay!, Biopharm. Drug Dispos., 33, 47, 10.1002/bdd.1776

Schreiber, 1996, Regulation of vesicular pH in liver macrophages and parenchymal cells by ammonia and anisotonicity as assessed by fluorescein isothiocyanate-dextran fluorescence, Biochem. J., 315, 385, 10.1042/bj3150385

Seelig, 1996, Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor, Biochemistry, 35, 4365, 10.1021/bi952434q

Shibata, 1983, Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine, J Gen Virol, 64, 1149, 10.1099/0022-1317-64-5-1149

Straus, 1964, Cytochemical observations on the relationship between lysosomes and phagosomes in kidney and liver by combined staining for acid phosphatase and intravenously injected horseradish peroxidase, J. Cell Biol., 20, 497, 10.1083/jcb.20.3.497

Tietz, 1990, Time-dependent effects of chloroquine on pH of hepatocyte lysosomes, Biochem. Pharmacol., 40, 1419, 10.1016/0006-2952(90)90414-G

Tycko, 1982, Rapid acidification of endocytic vesicles containing alpha 2-macroglobulin, Cell, 28, 643, 10.1016/0092-8674(82)90219-7

Ufuk, 2015, In vitro assessment of uptake and lysosomal sequestration of respiratory drugs in alveolar macrophage cell line NR8383, Pharm. Res., 32, 3937, 10.1007/s11095-015-1753-8

Ufuk, 2017, In vitro and in silico tools to assess extent of cellular uptake and lysosomal sequestration of respiratory drugs in human alveolar macrophages, Mol. Pharm., 14, 1033, 10.1021/acs.molpharmaceut.6b00908

Vestal, 1980, Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines, J. Pharmacol. Exp. Ther., 214, 106

Yata, 1990, Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats, Pharm. Res., 7, 1019, 10.1023/A:1015935031933

Yayoi, 2001, Specific localization of lysosomal aminopeptidases in type II alveolar epithelial cells of the rat lung, Arch. Histol. Cytol., 64, 89, 10.1679/aohc.64.89

Zhao, 2011, Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review, Clin. Pharmacol. Ther., 89, 259, 10.1038/clpt.2010.298

Zheng, 2011, Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine, J. Pharmacol. Exp. Ther., 336, 661, 10.1124/jpet.110.175679